Labtech sign exclusive agreement with ICx Technologies for distribution of Surface Plasmon Resonance Technology in the UK and Ireland
1 Feb 2008Surface Plasmon Resonance has long proved to be an invaluable tool for scientists involved in characterizing biomolecular interactions such as antibody selection and screening, drug discovery, ligand fishing, binding specificity and gene regulation. However, access to this technology has traditionally been limited due to the high cost of instrumentation, leaving researchers dependent on core facilities.
The SensiQ® range from ICx Technologies brings affordable SPR to the field of biomolecular interaction analysis for the first time. The range includes three models, the manual SensiQ® Discovery, manual injection instrument, the dual channel, semi-automated SensiQ® and the SensiQ® Pioneer fully automated instrument for high throughput users.
“We are delighted to be working with nomadics on this exciting opportunity to bring SPR into research labs.” says Dr Brian Page, Managing Director of Labtech International. “Although the high specification and performance of these instruments makes them well suited for pharma applications, for which they have been designed, SensiQ® affordability means that this technology is no longer the reserve only of big pharmas”.
Labtech International are a company dedicated to serving the scientific community of the United Kingdom, Ireland and France. Established in 1993, Labtech supply their customers with a unique collection of innovative laboratory equipment, software and consumables, assembled to offer scientists new ways to help solve their analytical challenges. A global approach to sourcing cutting edge new technologies allows Labtech to provide scientists with new perspectives and tools to accelerate discovery and maximise the impact of their research budgets.
With a focus on understanding the applications and requirements of our customers, Labtech invests heavily in providing first class technical and service support as well as an efficient sales process.
Labtech and ICx Technologies will be working closely to help develop new applications and validate customers assays.